Yesterday, it emerged that China Dasheng Biotechnology Co (OTCMKTS:CDBT) had signed a work order for manufacturing and fitting Y9MX new series engine into a vehicle. The agreement had actually been signed with its subsidiary unit Cycclone & Y Engine Developments Pty Ltd. It was a significant new announcement from the company and one that could interest investors as well.
On Friday, CDBT stock soared 22.78% to $0.0380 with more than 5K shares, compared to its average volume of 5.90K shares. The stock moved within a range of $0.0380 – 0.0380 after opening trade at $0.0380.
Cycclone Magnetic Engines Enters Work Order to Produce and Fit Y9XM Engine
Cycclone Magnetic Engines operates a total of three facilities in Australia. The facilities are located in Arundel, Bangalow and Molendinar. It was announced yesterday that it had started work at the Bangalow unit for the purpose fulfilling the work order that the company signed up for.
The initial plan of Cycclone Magnetic Engines is to manufacture and develop a total of 50 engines that it would supply for non-essential use. The engines that are going to be supplied for non-essential use are going to be supplied for agricultural needs for items like water pumping and others.
The company is focussed on producing, developing and testing products so as to become a certified producer for the market. Once that happens, Cycclone Magnetic Engines would look into the possibility of approaching clients for the purpose of manufacturing products.